BMY - 2seventy stock hits new 52-week low on Abecma sales report
2023-10-26 17:17:24 ET
More on 2seventy bio
- bluebird bio And 2seventy bio - Spinner And Spun: The Better Bet In Cell Therapy
- 2seventy bio, Inc. 2023 Q2 - Results - Earnings Call Presentation
- 2seventy bio, Inc. (TSVT) Q2 2023 Earnings Call Transcript
- 2seventy bio stock gains before the bell on job cuts, restructuring
- Seeking Alpha’s Quant Rating on 2seventy bio
For further details see:
2seventy stock hits new 52-week low on Abecma sales report